<![CDATA[WACKER Investor Relations]]> https://www.wacker.com/cms/media/global/image/layout/logo.png <![CDATA[Wacker Chemie AG - Creating Tomorrow's Solutions]]> <![CDATA[WACKER's Newly Acquired Pharmaceutical Protein Production SynCo Bio Partners B.V. in the Netherlands is Now Wacker Biotech B.V.]]> As of November 1, 2018, the pharmaceutical protein production facility in the Netherlands acquired by WACKER with its takeover of SynCo Bio Partners Luxembourg S.à r.l., will be renamed Wacker Biotech B.V.

]]>
<![CDATA[WACKER Starts Cystine Production in Spain]]> WACKER BIOSOLUTIONS, the life sciences division of the WACKER Group, has begun producing fermentation-generated cystine at its new site in León, Spain.

]]>
<![CDATA[WACKER’s Sales and Earnings Rise in Q2 2018 Amid Strong Performance in Chemicals]]> Thanks to the strong performance of its chemical business, Wacker Chemie AG’s sales and EBITDA continued to grow in the second quarter of 2018, both year over year and quarter over quarter.

]]>
<![CDATA[WACKER POLYMERS to Raise Prices for Dispersions and Dispersible Polymer Powders]]> WACKER POLYMERS is raising its prices for vinyl-acetate-ethylene-based copolymer dispersions, dispersible polymer powders and solid resins of its VINNAPAS®, VINNOL®, ETONIS®, VINNACEL® and SMARGO® brands worldwide.

]]>
<![CDATA[WACKER achieves Q1 2018 Sales on par with a Year earlier and substantially increases Earnings]]> Wacker Chemie AG’s Q1 2018 sales were on par with a year ago, while its earnings before interest, taxes, depreciation and amortization (EBITDA) were substantially higher year over year.

]]>
<![CDATA[WACKER Opens New Production Site for Silicones in South Korea]]> Wacker Chemie AG today opened a new production site for silicone elastomers in South Korea.

]]>
<![CDATA[WACKER Strengthens Its Pharmaceutical-Protein Business and Buys Dutch Biotechnology Plant]]> Wacker Chemie AG has acquired a Dutch site for manufacturing biopharmaceuticals, live microbial products and vaccines, plus the associated business, from SynCo Bio Luxembourg S.à.r.l..

]]>
<![CDATA[After a good fiscal year 2017, WACKER expects further sales and earnings growth for 2018]]> As already reported, Wacker Chemie AG met or surpassed its own projections for all its performance indicators in 2017.

]]>
<![CDATA[Supervisory Board extends the contract of Executive Board Member Auguste Willems until 2023]]> Today, Wacker Chemie AG’s Supervisory Board re-appointed Auguste Willems (59) to the Executive Board for another five years.

]]>
<![CDATA[WACKER ends 2017 with Substantial Sales and Earnings Growth]]> Following a good fourth quarter, Wacker Chemie AG achieved its sales and earnings targets for full-year 2017.

]]>